The New Jersey Institute of Technology's
Electronic Theses & Dissertations Project

Title:	An analysis of the periodicity of the cell cycle and apoptotic regulatory proteins in prostate xenografts using anova and cosinor methods
Author:	Hosdaghian, Aleen
View Online:	njit-etd2004-004 (x, 62 pages ~ 5.3 MB pdf)
Department:	College of Computing Sciences
Degree:	Master of Science
Program:	Computational Biology
Document Type:	Thesis
Advisory Committee:	Recce, Michael (Committee co-chair) Blumenthal, Rosalyn D. (Committee co-chair) Ariyan, Zaven S. (Committee member)
Date:	2004-01
Keywords:	Circadian rhythms Cell cycle Apoptotic regulatory protiens
Availability:	Unrestricted
Abstract:	Circadian rhythms have been found in both plants and animals, in normal tissues as well as in most tumors and human cancers. By following these rhythms in healthy and cancerous tissue, it has been possible to find optimal times to deliver a dose of drug, such that efficacy is maximized and toxicity to normal tissues is minimized. In this study, the periodicity of several cell cycle and apoptotic regulatory proteins were studied in two prostate cancer models against a dietary therapeutic agent, Selenium. The ALVA-3 1 (androgen-independent) and PC-3 (androgen-independent) prostate cancer cell lines were grown in vivo, as a subcutaneous xenograft in mice and measured at seven different Hours After Light Onset (HALO). Measurements were taken at 3, 7, 10, 13, 17, 20 and 23 HALO, which is equivalent to 10 AM, 1 PM, 4 PM, 7 PM, 11 PM, 2 AM and 5 AM. The tumors were used to assess total expression of the protein of interest using an immunoblotting method, and the results were assessed by densitometry. Statistical analysis of the mice with the ANOVA and the COSiNOR methods showed that selenium treatment was most effective at HALO 13 at decreasing cell cycle and apoptosis-related proteins for ALVA-3 1. For PC-3 tumor lines, HALO 7 proved to be of highest expression while HALO 13 showed the lowest expression. The selenium treated tumors showed inhibitory effects via lower expression levels throughout both tumor trials.